tiprankstipranks
Analyst Profile
Followed by 4 other investors
.
Yi Dan Wang

Yi Dan Wang

Deutsche Bank
Wall Street Analyst
Ranked #4,416 out of 8,050 Analysts on TipRanks (#10,329 out of 21,576 overall experts)

Success Rate

56%
9 out of 16 Profitable Transactions

Average Return

2.10%
Average return per transaction
Time Frame
1 Year
Compare to
No Benchmark
If you copied Yi Dan Wang's ratings since 2015 and opened each position for the duration of 1 Year:
56.25% of your transactions would have been profitable with an average return of 2.1%

Stock Rating Distribution

16Ratings
68.75% Buy
25.00% Sell
6.25% Hold
Distribution of Yi Dan Wang's ratings

Additional Information

Main Sector:Healthcare
Geo Coverage:
United KingdomUK Market
United StatesUS Market

Best Rating

Stock:
Coloplast A/S
(0QBO)
Rating Type:Buy
Dates:Apr 17, 2019 - Apr 17, 2020
Gain:57.30%
The most profitable rating made by Yi Dan Wang

Yi Dan Wang's Stock Coverage

Company Name
Date
Position
Action
Price Target
Success Rate
Avg Return
No. of Ratings
Plantronics
Jul 21, 2015
Buy
Reiterated
$65.00
(63.03% Upside)
0%
-16.03%
3
Smith & Nephew Snats
May 03, 2018
Sell
Downgraded
75%
+3.48%
4
Smith & Nephew
Dec 07, 2018
Hold
Upgraded
135,000.00p
(12812.48% Upside)
0.00%
1
Demant
Dec 07, 2018
Buy
Upgraded
$38.92
(3.10% Upside)
100%
+2.10%
1
ConvaTec
May 07, 2019
Sell
Reiterated
113.00p
(-52.44% Downside)
0%
-45.00%
3
Coloplast A/S
Jul 02, 2019
Buy
Reiterated
kr725.00
(-13.24% Downside)
100%
+49.73%
3
B.R.A.I.N. Biotechnology Research and Information Network
Sep 03, 2019
Buy
Reiterated
€24.00
(232.32% Upside)
0%
-8.40%
1
List of latest recommendations made by Yi Dan Wang. Click to expand and see Yi Dan Wang's performance on a particular stock
Disclaimer: TipRanks collects ratings and price targets of analysts by scanning publicly available reports on financial websites and by receiving reports directly from the analysts or from our users. The information displayed and the Analyst Profile statistics might not be accurate, complete, or up to date. The analyst ratings provided are entirely at the sole responsibility of the of the source publication. TipRanks holds no liability over the analysts' information, price targets, ratings or opinions expressed on the site.
Are We Missing a Rating?
Send us the equity research you are getting and become a Power User
Learn More